EFFICORT

This brand name is authorized in Ecuador, France, Hong Kong SAR China, Singapore.

Active ingredients

The drug EFFICORT contains one active pharmaceutical ingredient (API):

1
UNII 2340UP1L2G - HYDROCORTISONE ACEPONATE
 

Hydrocortisone is the main glucocorticoid secreted by the adrenal cortex. Hydrocortisone is an anti-inflammatory steroid. Its anti-inflammatory action is due to reduction in the vascular component of the inflammatory response and reduction in the formation of inflammatory fluid and cellular exudates.
 
Read more about Hydrocortisone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
D07AC16 Hydrocortisone aceponate D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III)
Discover more medicines within D07AC16

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 20.086-1-12-02
FR Base de données publique des médicaments 60252422, 65891566
HK Department of Health Drug Office 38271, 38272
SG Health Sciences Authority 08555P, 08556P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈